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DeLong and co-workers (19) nature of the induction of GSH and QR activity against HQ-induced cytotoxicity in bone marrow stromal cells (11, 12, 20) .
In these previous studies, we used tertbutylhydroquinone (tBHQ) and 1,2-dithiole-3-thione (DTT) as inducing agents. In the current study, only DTT was used as the inducing agent because it does not exhibit toxic effects against stromal cells in vitro at concentrations up to 250 ,uM. Additionally, DTT is classified as a monofunctional inducer that does not require interaction with the Ah receptor, which is defective in the DBA/2 strain of mouse, to elicit in vitro or in vivo GSH and/or enzyme induction (21, 22) .
The purposes of the current study were to determine if DTT protects DBA/2-derived stromal elements against the cytotoxic effects of HQ and if DTT also protects stromal cell functional activity by supporting myelopoiesis (Fig. 1) . Additionally, in vivo induction of QR activity within the bone marrow compartment was studied by feeding DTT to mice. (23) and pooled in either PBS or DMEM (no additions). The procedure used to establish primary adherent stromal cell cultures was a modification of the method of Zipori and Bol (24) . For adherent cell culture, we pooled cell suspensions from two or more animals and diluted them with DMEM supplemented with 15% FBS, 2 mM glutamine, 50 jiM 2-mercaptoethanol, 100 ,ug/ml L-asparagin, 100 IU/ml penicillin, and 100 jig/ml streptomycin, and then plated the suspensions on 100-mm tissue culture dishes, six Finally, on day 4, 72 hr after plating, we collected cells in the TC60 plates by scraping and centrifugation and stained them for esterase activity using two different substrates, ct-naphthylacetate (nonspecific) and cx-naphthylbutyrate (Sigma diagnostic kits 90-Al and 181-B). We assessed population differentials by determining the percent esterase-positive cells (macrophages) using standard light microscopy. Cells in the microtiter plates were stained with 0.4% crystal violet to determine survival (11) .
Assay of Dicoumarol-Inhibitable Quinone Reductase Activity. Quinone reductase (QR) activity was assayed by modification of the microtiter plate procedure developed by Prochaska and Santamaria (25) . In this procedure, QR activity is assessed by measuring the dicoumarol-inhibitable NADPH-dependent menadiol-mediated reduction of 3-(4,5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to the blue formazan dye. For this assay we trypsinized stromal cells, spun them at 1000 rpm for 10 min, discarded the supernatant, and lysed the cells by incubation at 370C for 10 min with 0.8% digitonin in 2 mM EDTA, pH 7.8. We assessed dicoumarol-inhibitable QR activity by adding the MTT reaction mixture, described below, to digitoninlysed stromal cells in the presence and absence of 60 gv dicoumarol. We recorded the spectrophotometric kinetic measurement of change in absorbance/min at 610 nm and calculated QR activity using the extinction coefficient for MTT (11, 300 M'1 cm' ) and expressed this value as nmol MTT reduced/min/mg protein.
Protein was quantified by a modified Lowry assay (26) or by the Bio-Rad protein assay (cat. no. 500-0006), which is based on the Bradford assay (27) . The MTT reaction mixture consisted of 25 mM Tris-Cl, 0.67 mg/ml bovine serum albumin, 0.01% Tween-20, 5 gM flavin adenine dinucleotide, 1 mM glucose-6-phosphate, 30 penicillin, and 100 pg/ml streptomycin. We then added cells to the agar mixture in no more than 100-p1 volumes to produce nucleated cell concentrations ranging from 4 to 20 x 10 cells/ml. Next we added 1 ml of the cell-agar suspension to gridded TC35 dishes containing 100 p1 of medium containing colony-stimulating factor. The colony-stimulating activity (CSA) was derived from medium that had been conditioned (12 days) by primary bone marrow stromal cells in the presence or absence of hydroquinone and/or DTT, as described below. After plating the cell-agar mixture, we allowed the agar to solidify at room temperature and incubated cultures at 370C in a humidified, 5% CO2 atmosphere for 8-12 days. Colonies consisting of at least 50 cells were scored from four replicate plates per test group using an inverted phase-contrast microscope. Hydroquinone Inhibition of Stromal Cell Ability to Support Myelopoiesis in Soft Agar. The effect of noncytotoxic doses of hydroquinone on the ability of DBA/2-derived stromal cells to support myelopoiesis was evaluated by treating 10-14-day cultures with 15 IM HQ and allowing the treated cells to condition the media for 12 days. We then collected this conditioned media and concentrated it for use in the CFU-G/M assay described above. Because the HQ was not removed during the media-conditioning period, we also determined CFU-G/Ms with conditioned media from untreated cells and added 20 IM HQ at the time of the colony-forming assay to control for any effect that residual HQ may have had on myelopoiesis (data not shown). Stromal cell conditioned media was concentrated approximately 10-fold in CentriCells (Polysciences, Inc.) with a 30,000 molecular weight cut-off point. We centrifuged the CentriCells at 2000g in a swingingbucket rotor for 30 min. After centrifugation, we determined the volume of the least concentrated sample and added DMEM with all additives to the other samples to bring them up to this volume so that all samples had an equal concentration. Individual CentriCells were used a maximum of 3 times, and concentrated volumes on any one run varied by ± 10%.
In Vivo Feeding of DTT. We acclimated DBA/2 mice (9-10-week-old males) and maintained them on an antioxidantfree powdered diet (AIN-76 purified diet with additional menadione and without ethoxyquin, TEKLAD DIETS) for 1 week. The test group was switched to diet containing 0.1% DTT, a concentration which was well tolerated by the animals based on appearance, weight, and activity levels.
After 6 days on test or control diet, animals were humanely euthanized by cervical dislocation, and bone marrow and livers were removed for enzyme analysis. We determined QR activity in whole bone marrow and in 24-hr primary cultures of bone marrow stromal cells. Livers were used as a positive control for QR and glutathione-Stransferase(GST) induction by DTT (data not shown).
In experiments to determine if in vivo feeding of 0.1% DTT could protect primary bone marrow cells against ex vivo challenge by hydroquinone, we treated animals as described immediately above and flushed bone marrow cells from the femurs using two mice per n. Equal numbers of nucleated cells were then plated into four TC1 00 dishes per n in the presence (two plates) or absence (two plates) of 50 P.M HQ, the LC50 dose for DBA/2 primary stromal cells. By this protocol each n had two test plates and two control plates to serve as its own control. Twenty-four hours later, we washed plates four times with PBS to remove dead and unattached cells. We then collected surviving, attached cells by scraping the plates with a rubber scraper and assessed survival by counting the number of surviving cells using a Coulter counter. Data are expressed as percent of survival for controls.
Statistics. Computations and statistics were performed using Lotus and Statpak software on an IBM personal computer. We used Students t-test (two-tailed) and one-way analysis of variance (ANOVA); values were considered significantly different ifp < 0.05 or if the F ratio had a significance < 0.05.
Results
Based on more extensive dose-response studies, the LC50 for hydroquinone was determined to be 49 ± 6 P.M for 3 x 104 stromal cells/well for DBA/2 (11). Twenty-four hours of pretreatment of stromal cells with 75 ,uM DTT protected against HQ-induced cytotoxicity, even at 95 pM HQ, a concentration that killed all cells in non-DTT-treated controls (12) .
When DBA/2-derived stromal cells were exposed to LC25 and LC50 concentrations of HQ and the proportion of macrophages versus fibroblasts to untreated cells were compared, the proportion of macrophages in the HQ-treated cells dropped from approximately 60% to about 40%, indicating that the macrophages were more sensitive to HQ than the fibroblasts (Table  1) . This is consistent with results obtained by Thomas and co-workers with cells derived from B6C3F1 mice (6 concentrated to express enough colonystimulating activity to support myelopoiesis. We used the second method to obtain the stromal cell-derived colonystimulating factors necessary for the support of myelopoiesis because conditioned media has the additional advantage of allowing us to treat the stromal cells without concurrently treating the naive bone marrow cells used in the colony-forming assay.
The data presented in Table 2 (29) . In vivo feeding of DTT does induce QR activity in rat liver (30) .
DBA/2 mice were fed 0.1% DTT mixed in the diet for 6 days. This dose of DTT was well tolerated as assessed by weight gain, activity levels, and overall appearance, which were comparable to control animals. At the end of the test period, we euthanized animals and cultured bone marrow cells for assessment of QR activity or treatment. Livers were also removed, perfused, and immediately frozen in liquid nitrogen to be used as a positive control, and 2-to 3-fold inductions of QR activity were observed (data not shown). Induction of hepatic QR activity was expected due to the fact that in vivo induction by a number of phase II inducers has been demonstrated in the DBA/2 mouse (22) . As shown in Table 3 , there was an increase in QR activity in endogenous bone marrow preparations as well as in 24-hr stromal cultures. DTT feeding increased QR activity in whole bone marrow preparations from 17 to 22 nmol/min/mg protein, and from 30 to 46 nmol/min/mg protein in 24-hr stromal cells (Table 3 ). In keeping with the induction of QR activity within the bone marrow compartment, in vivo feeding of DTT protected primary stromal cells against a subsequent in vitro challenge with 50 jiM HQ during the first 24 hr in culture (Table 4 ).
Discussion
The concept of chemoprotection, that is, protection from the toxicity of one chemical by the administration of another chemical, was first observed more than 50 years ago in rodents when skin tumors were produced by local applicatlion of carcinogens (17, 18) . Mechanistically, chemoprotection has been associated with the induction of three classes of detoxification enzymes: enzymes involved in ascorbic acid biosynthesis, the microsomal P450 class of enzymes, and soluble, cytosolic enzymes known collectively as phase II detoxification enzymes (17, 31) . Extensive research since that time has demonstrated that induction of phase II enzymes as well as Significantly different from respective control by Student's t-test, p<0.05. glutathione is a useful strategy for enhancing the clearance and/or detoxification of chemically reactive intermediates (14, 18, 32) . Quinone reductase (QR) has also been shown to be coordinately induced with other electrophile-processing phase II enzymes such as glutathione-S-transferases (14, 17, 18) . Recently, the protection of hepatoma cells against the toxicity of a number of redox-active xenobiotics has been linked to the in vitro induction of QR (19) . A class of chemicals currently under extensive investigation as chemoprotective agents are the dithiolethiones (33) . Bone marrow is a target organ for toxicities induced by a spectrum of chemicals (34) including the environmental pollutants benzene and benzo[a]pyrene (BaP) (35) . The stromal cell component from bone marrow is particularly susceptible to toxicity induced by several redox-active metabolites of the hematotoxin benzene, such as benzoquinone and HQ (12, 28, 36) . Consequently, it was of great interest when recent studies in our laboratory demonstrated that bone marrow-derived stromal cells could also be protected against hydroquinone-induced cytotoxicity by pretreating cells with the phase II enzyme inducer DTT (12) . This observation prompted us to further examine whether the inducing activity of DTT in bone marrow stroma also protects against HQ-induced modulation of stromal-dependent myelopoiesis. In this study, we have also examined whether in vivo feeding of DTT induces QR activity within the stromal compartment and as such protects against the in vitro toxicity of HQ.
As shown in Table 1 , HQ was toxic to DBA/2-derived bone marrow stroma and demonstrated preferential killing of stromal macrophages. Primary cultures of bone marrow stroma are not a pure population of one type of cell; these cultures consist of a 60:40 mixture of resident macrophages and fibroblastoid cells, respectively (24, 37) . Primary stromal macrophages were more sensitive to HQ than the fibroblastoid stromal cells, as illustrated by the shift in the ratio of macrophages to fibroblasts from 60:40 to 40:60 after LC25 or LC50 doses of HQ (Table 1) . Pretreatment of the stromal macrophages and fibroblasts with DTT prevented this shift in ratio ( Table 1) .
The data described above complement previous studies performed in our laboratory comparing QR and GST activities and GSH concentration between cell types within the bone marrow stroma and between strains of mice with differential susceptibility to HQ-induced cytotoxicity.
These previous studies demonstrated that basal QR activity was lower in the stromal macrophage versus the stromal fibroblast, with activity for the mixed population falling between the values for the individual cell types (12) . The lower QR activity in the more HQ-sensitive cell type mimicked the difference in QR activity previously observed between whole stromal populations from strains of mice with differential sensitivity to HQ-induced toxicity (12) . These data also agree with previous data evaluating the effect of DTT on stromal cell QR and GST activities and cytosolic GSH concentration. Treatment of primary cells in vitro with 75 jM DTT resulted in a 2-fold increase in QR activity in DBA/2 stroma and about a one-third increase in cytosolic GSH concentration (12) . Unlike other tissues (22, 32) , DTT treatment of primary bone marrow stromal cells had no inductive effect on GST activity. Thus, the increase of both GSH concentration and QR activity appear to be important in the chemoprotection against HQ-induced toxicity provided by DTT. This hypothesis was substantiated by the effects of dicoumarol, an inhibitor of QR activity (31), on HQ toxicity and through protection by DTT. Dicoumarol potentiated HQ toxicity and interfered with DTT protection against HQ-induced toxicity in stromal cells (12, 38) . Likewise, depletion of GSH in stromal cells by buthionine sulfoximine potentiated HQ-induced toxicity (39) .
Because enhanced stromal cell survival was used as an index of chemoprotection from HQ-induced toxicity, we thought it was important to also examine a noncytotoxic functional endpoint of toxicity induced by HQ. A potential target for nonlethal toxicity is the ability of stromal cells to support myelopoiesis, which is an in vivo function of the stromal cells. It has been previously demonstrated that purified populations of bone marrow stromal fibroblasts can support myelopoiesis to only 50% of the number of colonies that are supported by mixed populations of stromal fibroblasts and stromal macrophages.
Purified stromal macrophages cannot support significant myelopoiesis (28) . The data presented in Table 2 demonstrate that noncytotoxic concentrations of HQ impaired the ability of stromal cells to support myelo-poiesis by approximately 40%. This indicated again that the stromal macrophage was the preferential target of noncytotoxic concentrations of HQ, with the amount of observed myelopoiesis being supported primarily by stromal fibroblasts. This is in agreement with the previous data demonstrating preferential killing of stromal macrophages over stromal fibroblasts by HQ (Table 1) .
Pretreatment of cells by DTT protected the primary stromal cells from both forms of HQ-induced toxicity (Tables 1 and 2 ).
Chemoprotection of primary bone marrow stromal cells by DTT was also observed after in vivo feeding of DTT. Using QR as a biomarker of the inducing effect of DTT within the bone marrow, a 1.5-fold increase in QR activity was observed in 24-hr stromal cultures derived from animals that had received 0.1% DTT in the diet for 6 days (Table 3) . This inductive activity of DTT was reflected in protection against the cytotoxic effects of 50 FM HQ in stromal cells derived from DTT-treated animals compared to stromal cells derived from animals that did not receive DTTin vivo (Table 4 ). More importantly, based on the data presented in Table 2 , a protective effect against HQinduced alterations in myelopoiesis would also be expected. Thus, the inducibility of cellular defense mechanisms and xenobiotic-processing enzymes by chemoprotective agents such as DTT may prove to be a useful strategy in preventing chemically induced cell dysfunction and death in the bone marrow (Fig. 1) . In this regard, one of the advantages of an agent like DTT is that it is a monofunctional inducer and as such does not require interaction with the Ah receptor for its inducing activity (22) . The availability of chemicals that function as inducers primarily of phase II enzymes independent of the Ah receptor is important from the perspective that genetic differences in the Ah locus are relevant to humans as well as to different strains of mice (21) . 
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